| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.08 |